(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.8%.
Precision Biosciences's earnings in 2025 is -$21,986,000.On average, 1 Wall Street analyst forecast DTIL's earnings for 2025 to be -$50,673,229, with the lowest DTIL earnings forecast at -$50,673,229, and the highest DTIL earnings forecast at -$50,673,229. On average, 1 Wall Street analyst forecast DTIL's earnings for 2026 to be $5,211,470, with the lowest DTIL earnings forecast at $5,211,470, and the highest DTIL earnings forecast at $5,211,470.
In 2027, DTIL is forecast to generate $10,312,058 in earnings, with the lowest earnings forecast at $10,312,058 and the highest earnings forecast at $10,312,058.